Molecular Subgroups of Glioblastoma– an Assessment by Immunohistochemical Markers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular Subgroups of Glioblastoma– an Assessment by Immunohistochemical Markers

Published:2017-09-26 Issue:1 Volume:25 Page:21-31
ISSN:1219-4956
Container-title:Pathology & Oncology Research
language:en
Short-container-title:Pathol. Oncol. Res.

Author:

Nagy Ádám,Garzuly Ferenc,Padányi Gergely,Szűcs Iván,Feldmann Ádám,Murnyák Balázs,Hortobágyi Tibor,Kálmán Bernadette

Funder

Hungarian Brain Research Programme

GINOP

University of Pecs

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/article/10.1007/s12253-017-0311-6/fulltext.html

Reference54 articles.

1. Stupp R, Mason WP, Van Den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996

2. Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf U, Brooks WH et al (1980) Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303(23):1323–1329

3. Laperriere N, Zuraw L, Cairncross G, Cancer Care Ontario Practice Guidelines Initiative Neuro-Oncology Disease Site Group (2002) Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 64(3):259–273

4. Chaurasia A, Park SH, Seo JW, Park CK (2016) Immunohistochemical analysis of ATRX, IDH1 and p53 in Glioblastoma and their correlations with patient survival. J Korean Med Sci 31(8):1208–1214

5. Eidel O, Burth S, Neumann JO, Kieslich PJ, Sahm F, Jungk C et al (2017) Tumor infiltration in enhancing and non-enhancing parts of Glioblastoma: a correlation with histopathology. PLoS One 12(1):e0169292

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histopathological Spectrum of Gliomas and Its Immunohistochemical Correlation in a Tertiary Care Setup;Cureus;2024-07-21

2. Inhibition of glioblastoma cell proliferation and invasion by the choline-kinase inhibitor JAS239 varies with cell type and hypoxia;2024-01-20

3. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker;Cells;2023-03-08

4. The “Superoncogene” Myc at the Crossroad between Metabolism and Gene Expression in Glioblastoma Multiforme;International Journal of Molecular Sciences;2023-02-20

5. Prognostic Factors of Survival in Glioblastoma Multiforme Patients—A Retrospective Study;Diagnostics;2022-10-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3